FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

AstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - The UK is ‘a hostile environment’ for ...

Analysis from the Thrombotic Thrombocytopenia Syndrome Consortium has provided critical insights into the rare but serious ...

The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...

Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a ...

More than 450,000 extra Queenslanders will be eligible to receive the Pfizer vaccine after a change to the advice around AstraZeneca, with the Health Minister warning of possible delays as the rollout ...

AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...